$ORRF

ORRSTOWN FINANCIAL SERVICES INC (ORRF): Results of Operations and Financial Condition

ORRSTOWN FINANCIAL SERVICES INC (ORRF) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex9912026-q2earningsrelease.htm EX-99.1 Document Exhibit 99.1 FOR IMMEDIATE RELEASE: Orrstown Financial Services, Inc. Reports Second Quarter 2026 Results • Net income of $21.2 million, or $1.09 per diluted share, for the three months ended June 30, 2026 compared to net

Original reporting
Published Jul 22, 2026, 12:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 12:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$ORRF
Neutral
medium confidence
Mentioned
$ORRF
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$ORRFNeutralMed
01

Why it matters

Key trading inputs are the quarter’s earnings and margin trajectory, credit quality (nonaccrual ratio), balance-sheet growth (loans), capital/tangible book changes, and a specific subordinated-note redemption that affects future interest expense.

02

Market read

Traders can update near-term expectations for ORRF’s earnings power using the disclosed NIM, credit metrics, tangible book value, and the debt redemption mechanics.

03

What to watch

Deposit mix shifted toward lower-cost demand and money market, and nonaccruals improved to 0.58%. Those credit and funding details could outweigh the headline NIM decline for some valuation frameworks.

Relevance 7/10Novelty 6/10Timing: after-hours SEC 8-K filing for Q2 2026 results

Background

This SEC 8-K includes Orrstown Financial Services’ Q2 2026 results (Item 2.02) with an earnings release exhibit.

Company-level read

Ticker impact

$ORRFNeutralMedium confidence
Context

Orrstown Financial Services reported Q2 2026 net income of $21.2M, NIM 3.87%, and redeemed $31.0M subordinated notes on June 30, 2026.

Expected impact

Near-term bias likely neutral to slightly negative unless investors focus on tangible book value growth and the expected benefit from the redeemed notes.

Evidence & confidence

The filing provides multiple decision-relevant datapoints (earnings, NIM, nonaccrual ratio, loan growth, capital/tangible book, and a specific debt redemption) but no explicit forward guidance beyond qualitative statements.

Market effects

Regional bank read-through: redemption of subordinated debt and NIM sensitivity to amortization can influence how investors model earnings power.

Limited to the company’s footprint in Pennsylvania and surrounding markets; no broader regional banking shock indicated.

Low; this is a single-bank earnings and balance-sheet update with no cross-border or macro policy catalyst.

Counterpoint

Investors may discount the quarter-to-quarter NIM dip as largely accounting-driven (amortization of the redeemed notes’ fair value mark) and instead price the longer-run benefit of removing that subordinated cost.

Key entities

  • Orrstown Financial Services, Inc.

    NASDAQ-listed parent company of Orrstown Bank; reported Q2 2026 results and redeemed $31.0M subordinated notes.

  • Orrstown Bank

    Bank subsidiary referenced in the earnings release for loan, deposit, and liquidity metrics.

Related articles

$MURMedAI 8/10

Murphy Oil Sees Sharp Profit Increase

Murphy Oil Corp reported Q2 2026 adjusted net income of $225.8 million, nearly six times Q2 2025, as higher oil prices offset lower production and weaker gas. Adjusted EPS was $1.55 vs $1.51 consensus. Revenue rose to $926.3 million. Murphy kept its $0.35 dividend and raised 2026 capex midpoint to $1.55 billion.

$GSBDMed

Goldman Sachs BDC Q2 Earnings Call Highlights

Goldman Sachs BDC (NYSE:GSBD) reported no incentive fee in Q2, citing its three-year total-return lookback provision. NAV was $12.06/share at June 30 vs $12.17 in Q1. The board declared a Q3 base dividend of $0.32/share plus $0.03 supplemental. Investments were $3.2B fair value, non-accrual 2.9%, and net debt-to-equity 1.35x.

$HBBMed

Hamilton Beach Brands Q2 Earnings Call Highlights

Hamilton Beach Brands (HBB) reported Q2 gross margin of 26.1% excluding tariff-related benefits, and said it expects 2026 revenue growth in the mid-single-digit range. Management forecast full-year gross margin to improve modestly and operating profit to decline by a high-single-digit percentage. Operating cash flow is expected at $35M to $45M. HBB ended with net cash of $51.5M.

$GXOMed

GXO Logistics Q2 Earnings Call Highlights

GXO Logistics reported Q2 results and said it secured over $1 billion in expected incremental new-business revenue for 2026 and about $353 million for 2027. Management cited a $2.7 billion sales pipeline after quarter end. Operating cash flow was $76 million, free cash flow positive $12 million, cash $769 million, and net leverage 2.6x. GXO plans to target EBIT margins above 6% and deploy AI across ~50 sites in 2026.

$GRNDMed

Grindr Q2 Earnings Call Highlights

Grindr (NYSE:GRND) said free users remain central to its strategy, while AI tools are boosting engineering productivity. Management estimated engineering output rose about 2.5x from July 2025 to April 2026 with similar headcount, supporting a 39% to 42% adjusted EBITDA margin outlook. EDGE AI premium tier rollout is planned for later in fall; operating expenses ex cost of revenue were $71M vs $53M.

$HAEMedAI 8/10

Haemonetics Q1 Earnings Call Highlights

Haemonetics (NYSE:HAE) reported Q1 interventional technologies returning to 3% organic growth, with vascular closure led by VASCADE MVP and MVP XL momentum in the U.S. Apheresis revenue rose 6% organically to $191M and plasma revenue grew 8% organically as Persona PLUS rollout accelerates. Haemonetics raised FY2027 revenue guidance to 5% to 8% reported and 4% to 7% organic.